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Background: The basic perineural catheter design has changed minimally 
since inception, with the catheter introduced through or over a straight needle. 
The U.S. Food and Drug Administration recently cleared a novel perineural 
catheter design comprising a catheter attached to the back of a suture-
shaped needle that is inserted, advanced along the arc of its curvature pulling 
the catheter past the target nerve, and then exited through the skin in a sec-
ond location. The authors hypothesized that analgesia would be noninferior 
using the new versus traditional catheter design in the first two days after 
painful foot/ankle surgery with a primary outcome of average pain measured 
with the Numeric Rating Scale.
Methods: Subjects undergoing painful foot or ankle surgery with a con-
tinuous supraparaneural popliteal-sciatic nerve block 5 cm proximal to the 
bifurcation were randomized to either a suture-type or through-the-needle 
catheter and subsequent 3-day 0.2% ropivacaine infusion (basal 6 ml/h, 
bolus 4 ml, lockout 30 min). Subjects received daily follow-up for the first 
four days after surgery, including assessment for evidence of malfunction or 
dislodgement of the catheters.
results: During the first two postoperative days the mean ± SD average 
pain scores were lower in subjects with the suture-catheter (n = 35) com-
pared with the through-the-needle (n = 35) group (2.7 ± 2.4 vs. 3.4 ± 2.4) 
and found to be statistically noninferior (95% CI, −1.9 to 0.6; P < 0.001). 
No suture-style catheter was completely dislodged (0%), whereas the tips of 
three (9%) traditional catheters were found outside of the skin before pur-
poseful removal on postoperative day 3 (P = 0.239).
conclusions: Suture-type perineural catheters provided noninferior analge-
sia compared with traditional catheters for continuous popliteal-sciatic blocks 
after painful foot and ankle surgery. The new catheter design appears to be 
a viable alternative to traditional designs used for the past seven decades.
(ANESTHESIOLOGY 2020; XXX:00–00)
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editor’S PerSPective
What We Already Know about This Topic
• The fundamental design of perineural catheters has changed little 
since they were first introduced
What This Article Tells Us That Is New
• A novel catheter attached to the back of a suture-shaped needle 
can be inserted under ultrasound guidance to provide popliteal-sci-
atic nerve blockade
• In the first two days after foot and ankle surgery, analgesia provided 
using the suture-type catheters was found to be noninferior to that 
provided by conventional through-the-needle catheters
A peripheral nerve block can provide potent analgesia after surgery. However, to prolong the effects beyond 
the duration of a single injection of local anesthetic, a peri-
neural catheter must be inserted to allow repeated or con-
tinuous local anesthetic administration.1 The method of 
catheter insertion has remained relatively unchanged since 
the first catheter-based continuous peripheral nerve block 
report in 19512: a straight, hollow-bore needle is inserted 
to the desired perineural location and a catheter is subse-
quently inserted either over or through the linear needle.3 
The needle is then removed, leaving the catheter which is 
secured at the single (entry) site.
However, the U.S. Food and Drug Administration 
recently cleared a novel perineural catheter design for use 
in the United States. The new system comprises a cathe-
ter attached to the back of a hollow, suture-shaped nee-
dle (fig. 1) that is inserted into the skin, passed adjacent to 
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the target nerve with ultrasound guidance, and then exits 
through skin in a second location (fig. 2).4 As the needle 
is advanced along the arc of its curvature it pulls the cath-
eter through the tissue and adjacent to the target nerve.5 
The needle is removed from the indwelling catheter and 
the catheter can then be pulled from either skin exit point 
to align its orifice immediately adjacent to the target nerve 
using ultrasound visualization (fig.  3).6 Both ends of the 
catheter are secured and local anesthetic is administered 
through a port on the proximal end of the catheter (fig. 1).
This new catheter design has been described in vari-
ous case series.5–7 However, it remains unknown how the 
new design compares with the traditional through-the-
needle method. Therefore, we designed and executed a 
randomized, subject-masked, parallel-arm study compar-
ing popliteal-sciatic catheters inserted using the new and 
traditional techniques. We hypothesized that pain would 
be noninferior using the new suture-type catheter com-
pared with a through-the-needle perineural catheter in the 
first two days after painful foot/ankle surgery. The primary 
outcome measure was the average pain level during the 
first two postoperative days as measured on the Numeric 
Rating Scale. Secondary outcomes included pain levels at 
other time points, opioid consumption, opioid-related side 
effects, sleep disturbances, sensory and motor deficits, satis-
faction with postoperative analgesia, fluid leakage, and com-
plete catheter dislodgement.
Materials and Methods
This parallel group study adhered to Good Clinical 
Practice quality standards and ethical guidelines defined 
by the Declaration of Helsinki. Study protocol approval 
as well as data and safety oversight were conducted by the 
University of California San Diego Institutional Review 
Fig. 1. Photograph of both the 100-mm (upper) and 160-mm (lower) suture-catheter assemblies. Note that the adapter contains a port for 
injecting fluid via the needle tip and the port on the catheter injects via the orifice.
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Board (No. 170834; San Diego, California). Written, 
informed consent was obtained from all subjects partici-
pating in the trial. The trial was prospectively registered at 
clinicaltrials.gov (NCT03442036; Principal Investigator: 
Brian Ilfeld, M.D., M.S.; date of registration: February 22, 
2018) before initiation of enrollment. The full protocol is 
available at clinicaltrials.gov.
Enrollment was offered to all adults who met study 
criteria undergoing painful unilateral ambulatory foot or 
ankle surgery with a planned popliteal-sciatic perineural 
catheter for postoperative analgesia at a single institution. 
Exclusion criteria included clinically-apparent neuropa-
thy in the surgical extremity, chronic high-dose opioid use 
(defined as daily use for more than 4 weeks before surgery 
Fig. 2. (A) A wide sterile field is prepped, anticipating an exit site that is 6 to 8 cm medial to the needle entry site. (B) The suture-needle is 
inserted using in-plane ultrasound guidance. (C) After cutting the needle from the catheter, the catheter can be pulled in either direction to 
place the orifice directly adjacent to the target nerve. (D) Normal saline is injected via the catheter to confirm correct placement of the orifice. 
(E) Excess catheter at the exit site is clipped before securing the catheter. (F) The catheter is secured with clear, occlusive dressings at both 
the entry and exit sites.
Copyright © 2020, the American Society of Anesthesiologists, Inc. Unauthorized reproduction of this article is prohibited.Downloaded from anesthesiology.pubs.asahq.org by Brian M. Ilfeld on 02/06/2020
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Fig. 3. (A) The suture-needle is advanced under the sciatic nerve (SN) and normal saline (NS) is used to hydrodissect between the nerve 
and the underlying fascia. (B) Needle, NS, and SN are diagramed. (C) After withdrawing the needle to the lateral border of the nerve, NS is 
then used to hydrodissect between the SN and the overlying fascia. (D) SN, NS, and needle are diagramed. (E) Echogenic markings on the 
catheter are used to properly position the orifice directly adjacent to the SN. (F) The catheter with its echogenic markings are diagramed. (G) 
After placing the orifice adjacent to the SN, NS is used to confirm location. (H) Orifice, NS, and SN are diagramed.
Copyright © 2020, the American Society of Anesthesiologists, Inc. Unauthorized reproduction of this article is prohibited.Downloaded from anesthesiology.pubs.asahq.org by Brian M. Ilfeld on 02/06/2020
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of at least the equivalent of 20 mg oxycodone), a history 
of opioid misuse, surgery outside of ipsilateral sciatic and 
saphenous nerve distributions (e.g., iliac crest bone graft), 
patients with nerves deeper than 5 cm from the skin surface, 
pregnancy, an inability to communicate with the investi-
gators and hospital staff, and incarceration. Patients eligible 
for the study were called the night before surgery by one 
of the investigators to offer enrollment. If not available by 
telephone, patients were offered enrollment in person by 
one of the investigators before block placement if there was 
sufficient time to fully discuss the study and answer all ques-
tions. Only one patient who was offered enrollment in the 
study declined.
Preoperative Procedures
After applying standard American Society of Anesthesiologists 
(ASA; Schaumburg, Illinois) monitors, oxygen by facemask, 
and positioning the patient prone, intravenous midazolam 
and fentanyl were titrated for patient comfort while ensur-
ing patients remained responsive to verbal cues. A 13- to 
6-MHz 38-mm linear array ultrasound transducer (Edge 
II; SonoSite, USA) was used to visualize the sciatic nerve 
5 cm proximal to the bifurcation with a short-axis view. 
After confirming that this site was appropriate for catheter 
insertion, the subjects were randomized using a comput-
er-generated list (prepared by an investigator not involved 
in enrollment or data collection) in opaque, sealed security 
envelopes to one of two treatments groups (1:1 ratio) in 
blocks of four: (1) through-the-needle (traditional group) 
or (2) suture-catheter (suture group). The catheter site was 
sterilely prepped, draped, and the needle entry site anesthe-
tized with lidocaine 1% (3 ml).
Through-the-needle Insertion
A 17-guage Tuohy needle (FlexTip Plus; Teleflex Medical, 
USA) was inserted on the posterior aspect of the leg, 
from lateral to medial, using an in-plane, short-axis ultra-
sound-guided technique. Normal saline (5 to 10 ml) was 
used to hydrodissect around the sciatic nerve to facilitate 
catheter insertion. A 19-guage flexible, single-orifice peri-
neural catheter was inserted under ultrasound guidance. 
Correct location of the tip was confirmed by injection of 
normal saline (1 to 2 ml) with visualization of spread adja-
cent to the nerve. The catheter was then secured with clear, 
occlusive dressings. To facilitate tourniquet placement in 
the operating room, the catheter was taped up the lateral 
thigh and secured on the lower abdomen.
Suture-catheter Insertion
A short-beveled 19-guage suture needle (75 mm radius, 
160 mm length) joined to a 19-guage, single-orifice, 
nylon catheter (Certa Catheter, Ferrosan Medical Devices, 
Poland) was inserted on the posterior aspect of the leg, 
from lateral to medial, under ultrasound guidance using 
an in-plane technique. Normal saline (5 to 10 ml) injected 
through the hollow-bore needle was used to hydrodissect 
below (fig. 3, A and B) and then above (fig. 3, C and D) the 
sciatic nerve to facilitate spread of local anesthetic follow-
ing catheter insertion. The suture needle was then advanced 
under ultrasound guidance to an exit point approximately 
6 to 8 cm medial to the entry site. After anesthetizing the 
skin at the exit point with lidocaine 1% (1 to 2 ml), the 
needle was advanced through the skin and then removed 
(fig.  2E). The catheter was subsequently advanced under 
ultrasound visualization using the echogenic markings 
(fig. 3, E and F; Supplemental Digital Content 1, Echogenic 
Markings, http://links.lww.com/ALN/C180) to place the 
orifice directly adjacent to the sciatic nerve (Supplemental 
Digital Content 2, Markings to Orifice, http://links.lww.
com/ALN/C181). Proper position of the catheter was con-
firmed by injection of normal saline (1 to 2 ml) through the 
catheter and visualizing spread adjacent to the nerve (fig. 3, 
G and H). The excess catheter was then cut, leaving a tail 
approximately 1 cm long at the exit site. The entry and exit 
sites were secured with clear, occlusive dressings (fig. 3F). To 
facilitate tourniquet placement in the operating room, the 
catheter was taped up the lateral thigh and secured on the 
lower abdomen.
If a postoperative neurologic exam was desired by the 
surgeon, no local anesthetic was administered preopera-
tively. In cases in which no postoperative exam was antici-
pated, 20 ml 2% lidocaine with 5 to 10 µg/ml epinephrine 
was injected via the catheter immediately after placement. 
This was done under ultrasound visualization to confirm 
that the injection produced circumferential spread of the 
local anesthetic around the sciatic nerve (Supplemental 
Digital Content 3, Infusion of Local Anesthetic, http://
links.lww.com/ALN/C182). Successful block was defined 
as a decrease in temperature discrimination to ice after 
30 min in the tibial nerve distribution (unless the foot was 
not accessible because of a splint) as compared with sensa-
tion in the contralateral foot. For cases in which the sur-
geon desired a postoperative exam before local anesthetic 
administration, a bolus with the same lidocaine–epineph-
rine volume/concentration was performed in the postan-
esthesia care unit.
If the planned surgical procedure was anticipated to pro-
duce pain in the saphenous nerve distribution, a single-in-
jection saphenous nerve block was performed with 20 ml 
0.5% ropivacaine with 5 to 10 µg/ml epinephrine adminis-
tered via a 17-guage Tuohy needle under direct ultrasound 
visualization.
Intraoperative Procedures
Surgical anesthesia was provided with either preoperative 
administration of local anesthesia as part of the nerve block 
combined with propofol sedation, or general anesthesia 
consisting of inhaled volatile anesthetic with or without 
nitrous oxide in oxygen with opioids provided, as needed.
Copyright © 2020, the American Society of Anesthesiologists, Inc. Unauthorized reproduction of this article is prohibited.Downloaded from anesthesiology.pubs.asahq.org by Brian M. Ilfeld on 02/06/2020
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Postoperative Procedures
Subjects received a 3-day perineural infusion via electronic 
pump (ambIT PreSet, Summit Medical Products, Inc., USA) 
of ropivacaine 0.2% (basal 6 ml/h; 4 ml demand bolus; 30-min 
lockout) initiated in the recovery room along with a prescrip-
tion for oxycodone 5 mg tablets before discharge for supple-
mentary analgesia. Subjects were contacted by telephone for 4 
days after surgery to collect study outcome measures.
On the third postoperative day, subjects or their care-
takers were instructed to remove the perineural catheter. 
Subjects were instructed to remove the occlusive dressing at 
the skin entry site and slowly pull out the catheter. Subjects 
in the suture-catheter group were specifically instructed 
to leave the distal dressing in place until the catheter was 
completely removed, thus ensuring that the small tail at the 
exit site was pulled through the skin before sterile dressing 
removal to avoid contamination of the catheter track.
Outcome Measures
The first four items of the Brief Pain Inventory were col-
lected daily8: worst, average, least, and current surgical pain 
measured using the Numeric Rating Scale (provided ver-
bally to the investigator with specificity to the 0.1 unit). The 
primary outcome measure was average pain score on the first 
two postoperative days. Additional outcomes included daily 
opioid use, sleep disturbances attributable to pain (binary), 
opioid and local anesthetic infusion (e.g., perioral numb-
ness) side effects (binary), local anesthetic leakage (binary), 
complete catheter dislodgement (binary), degree of sensory 
block (measured on a 0 to 10 scale with 0 = no deficits and 
10 = completely insensate), satisfaction with postoperative 
analgesia (0 = very dissatisfied, 10 = completely satisfied), 
and the volume of local anesthetic consumed.
Statistical Methods
We assessed the balance of randomized groups on baseline 
and procedural characteristics using absolute standardized 
difference, defined as the absolute difference in means, mean 
ranks, or proportions divided by the pooled SD. Baseline 
variables with absolute standardized difference greater than 
0.46 (i.e., 1.96 ×√[1/n1 + 1/n2]) were considered imbal-
anced and were adjusted for in all analyses, as appropriate.9 
All analyses used modified intention-to-treat such that all 
patients randomized and receiving at least some of the study 
intervention were included.
We tested noninferiority of the suture method to the 
through-the-needle perineural catheter method on the pri-
mary outcome of average pain score and other continu-
ous secondary outcomes in the first two days after surgery 
using a one-tailed noninferiority t test at the 0.025 signifi-
cance level. We used an a priori noninferiority delta of 1.25 
for each pain score outcome and a ratio of means of 1.2 
for the cumulative log-transformed opioid consumption. 
Noninferiority was claimed if the upper 95% confidence 
limit for the treatment effect (estimated from analyses 
described below) was less than the specified noninferiority 
delta. P values were obtained from a one-tailed t test using 
a test statistic defined as T
NI
 = ( β ̂ – δ) / SE ( β ̂), where (β) 
is the estimated treatment effect, SE ( β ̂) is the estimated 
standard error of the treatment effect, and δ is the noninfe-
riority delta. If noninferiority was found, superiority would 
be tested in the same direction.10
We assessed the effect of suture-method to the through-
the-needle perineural catheter on each of four pain scores 
in the first two postoperative days using a repeated-mea-
sures linear mixed-effects model with an unstructured 
within-subject correlation structure adjusted for a variable’s 
imbalances at baseline (age was the only imbalanced vari-
able). The heterogeneity of the estimated treatment effect 
over time was assessed via the treatment-by-time interaction 
at a significance criterion of P < 0.15. A significant interac-
tion suggested that the treatment effect varies over time, in 
which case we estimated the treatment effect individually 
for each of two time points at the 0.0125 significance level 
using Bonferroni correction (0.025/2). Treatment effect 
estimates from these regression models were used to assess 
noninferiority of the suture versus through-the-needle 
methods, as described in the preceding paragraph.
For cumulative opioid consumption during the first two 
days after surgery, we first estimated the treatment effect of 
the suture method versus the through-the-needle method 
on log-transformed opioid consumption using linear 
regression and adjusting for age. If a patient did not receive 
opioids (amount = 0), 0.5 mg was added to facilitate the 
log-transformation.
We originally planned to estimate the effect of the 
treatment on the side effect of complete catheter dislodg-
ment as a secondary outcome for testing noninferiority. 
However, we observed no event in the suture method 
group. Therefore, we simply compared the groups using the 
Fisher exact test. We also compared the randomized groups 
on binary outcomes using chi-square or Fisher exact test, 
as appropriate.
Sample Size and Power Estimation
The study was designed to have 90% power at the 0.025 
significance level to detect noninferiority of the suture 
method to the through-the-needle perineural catheter on 
mean average pain score on the first two days after foot 
or ankle surgery. Assuming a noninferiority delta of 1.25 
points, a SD of 2.2,11 and a true difference of 0.5 points in 
the pain score favoring the suture method, a total sample 
size of 70 patients (35 per group) was required. SAS statisti-
cal software (USA) was used for all analyses.
results
Seventy subjects equally divided between the treatment 
groups were enrolled more than 12 months beginning in 
Copyright © 2020, the American Society of Anesthesiologists, Inc. Unauthorized reproduction of this article is prohibited.Downloaded from anesthesiology.pubs.asahq.org by Brian M. Ilfeld on 02/06/2020
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April 2018 and were included in all analyses (fig. 4). Subjects 
were summarized and compared on potentially confound-
ing baseline and procedural characteristics (table 1). All fac-
tors were balanced between two groups with the exception 
of age (suture group patients were more likely to be older) 
and surgical procedure (borderline imbalance). Age was 
adjusted for in all analyses. There were no missing data for 
any baseline variables or outcomes.
Primary Outcome
During the first two postoperative days the mean ± SD 
average pain scores were lower in subjects with the 
suture-catheter (n = 35) compared with the through-the-needle 
(n = 35) group (2.7 ± 2.4 vs. 3.4 ± 2.4) and found to be 
statistically noninferior (95% CI, −1.9 to 0.6; P < 0.001; 
table 2 and fig. 5). There was no evidence that the treat-
ment effect varied over time, with P = 0.908 for the treat-
ment-by-time interaction. We therefore assessed the overall 
treatment effect collapsing over time in the mixed effects 
model. Superiority was not found (P =0.282). (Of impor-
tance, although the suture method resulted in, on average, 
just over a half-point improvement in average pain, the CI 
for this effect includes zero, and by the CI is consistent with 
a true effect ranging from about a 2-point benefit to 0.5-
point harm. However, the primary analysis, determined a 
priori, was positive in that noninferiority was found.)
Secondary Analyses
We also found the suture method to be noninferior to the 
through-the-needle method on least pain in the first two post-
operative days, with an estimated mean (95% CI) Numeric 
Rating Scale difference of −0.4 (−0.9 to 0.2), P < 0.001, 
and on current pain with an estimated mean difference of 
−0.1 (−1.3 to 1.0), P = 0.009 (fig. 5). Superiority was not 
found on least (mean difference [95% CI] of −0.4 [−0.9 to 
0.2]; P = 0.222) or current pain (mean difference [95% CI] 
of −0.1 [−1.3 to 1.0]; P = 0.824). Although the actual mean 
scores for worst pain were slightly lower for the suture 
group (fig. 4), we could not conclude noninferiority given 
the upper limit of the CI (estimated mean difference [95% 
CI] of 0.0 [−1.5 to 1.5]) was above the predetermined non-
inferiority delta (P = 0.046). Of note, the inability to find 
the suture method noninferior for worst pain is not a find-
ing that it was inferior to through-the-needle. The best esti-
mate of the true effect is given by the estimated CI for the 
difference. The treatment effect of the two treatments on 
Fig. 4. Consolidated Standards of Reporting Trials diagram displaying the flow of participants through the study.
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each of the secondary pain scores was not found to change 
over the first two days (all treatment-by-time interaction P 
values > 0.15).
For the first two postoperative days, the median [inter-
quartile] cumulative opioid consumption was 15 [0, 35] 
mg in the Suture group and 25 [5, 45] in the traditional 
table 1. Demographics and Surgical Factors
Factor Suture-catheter (n = 35) through-the-needle (n = 35) absolute Standard differences*
Age, yr 53 ± 17 38 ± 13 1.01
Female, no. (%) 14 (40) 14 (40) 0.00
BMI, kg/m2 29.4 ± 5.8 27.6 ± 6.1 0.30
Procedure time, min 5 ± 3 5 ± 3 0.05
Local administration postop, no. (%) 3 (9) 2 (6) 0.11
Saphenous blocked, no. (%) 26 (74) 30 (86) 0.28
Surgical duration, min 103 ± 48 98 ± 49 0.09
Surgical procedure    
 Ankle open reduction internal fixation 13 21 0.47†
 Midfoot arthrodesis 6 4  
 Ankle fusion 6 1  
 Hallux deformity correction 3 2  
 Midfoot open reduction internal fixation 3 2  
 Exostosis excision 2 1  
 Calcaneus open reduction internal fixation 1 1  
 Anterior talofibular ligament repair 1 1  
 Achilles tendon repair 0 2  
Values are reported as mean ± SD or percentage of treatment group, as appropriate. BMI, body mass index.
*Absolute standard difference (ASD): The absolute difference in means mean ranks, or proportions divided by the pooled SD, with a criteria ASD ≥ 0.46 considered as imbalanced . 
†Comparing the first category (ankle open reduction internal fixation) with all others because of small counts.
table 2. Noninferiority Comparisons of the Suture Method versus Through-the-needle on Primary and Secondary Outcomes
Primary outcome
Suture-catheter  
(n = 35)
through-the-
needle (n = 35)
Mean difference*  
(95% ci)
noninferiority  
delta
noninferiority  
P value†
Superiority  
P value
Average pain scorea 2.7 ± 2.4 3.4 ± 2.4 −0.7 (−1.9 to 0.6) 1.25 0.001‡ 0.282
 POD 1 2.6 ± 2.6 3.3 ± 2.4     
 POD 2 2.7 ± 2.3 3.5 ± 2.4     
Secondary outcomes       
Worse painb 5.5 ± 3.4 5.7 ± 3.2 0.0 (−1.5 to 1.5) 1.25 0.046 NA
 POD 1 5.4 ± 3.8 5.8 ± 3.4     
 POD 2 5.6 ± 2.9 5.6 ± 3.1     
Least painc 0.8 ± 1.7 1.1 ± 1.4 −0.4 (−0.9 to 0.2) 1.25 < 0.001‡ 0.222
 POD 1 0.3 ± 1.1 0.7 ± 1.3     
 POD 2 1.3 ± 2.0 1.5 ± 1.5     
Current paind 2.3 ± 2.6 2.5 ± 2.4 −0.1 (−1.3 to 1.0) 1.25 0.009‡ 0.824
 POD 1 2.6 ± 2.7 2.9 ± 2.6     
 POD 2 2.0 ± 2.5 2.2 ± 2.2     
   Ratio of geometric means (95% CI)§    
Cumulative opioid consumption,  
mg in POD 1 and 2
15 [0, 35] 25 [5, 45] 0.6 (0.2 to 1.8) 1.20 0.108 NA
 POD 1 5 [0, 15] 10 [0, 20]     
 POD 2 10 [0, 20] 10 [0, 20]     
Values are reported as mean ± SD or median [interquartile range], as appropriate. POD, postoperative of day.
*Estimated from a linear mixed-effects regression model with an unstructured correlation structure. This model adjusted for age and used a noninferiority delta of 1.25 (i.e., the mean 
for the suture treatment can be no more than 1.25 points worse than the through-the-needle method to claim noninferiority). Noninferiority also claimed if upper limit of the 95% CI 
was less than 1.25. 
†Noninferiority P value obtained from a one-tailed t test using a test statistic defined as T
SENI
=
−βˆ δ
β
1
1
, where β1  is the estimated treatment effect, SEβ1  is the standard 
error of the treatment effect, and is the noninferiority delta; noninferiority was claimed if P < 0.025. 
‡Statistically significant (P < 0.025). 
§Estimated from a linear regression adjusted for age. a, b, c, dTreatment by time interaction P = 0.908, 0.609, 0.630, and 0.895, respectively, suggesting no evidence of treatment effect 
heterogeneity over time on any of the four pain scores.
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group (fig. 6). The estimated ratio of geometric means of 
the suture group compared with the traditional group on 
opioid consumption through the first two days was 0.6 
(95% CI, 0.2 to 1.8), adjusting for age. Noninferiority was 
not found on cumulative opioid consumption because the 
upper limit for the CI was above the noninferiority delta of 
1.2 (P = 0.108).
Whereas the suture method had a lower risk of leaking 
fluid (6% vs. 31%) compared with the through-the-needle 
method (P = 0.006), no differences were found between 
the treatment groups for any of the other secondary out-
comes (table  3). No suture-style catheter was completely 
dislodged (0%), whereas the tips of three (9%) traditional 
catheters were found outside of the skin before purposeful 
removal on postoperative day 3 (P = 0.239). Neither group 
experienced any local anesthetic side effects.
Adverse Events
One patient in the suture group who had undergone an 
open reduction, internal fixation of a pilon-type ankle 
fracture was readmitted approximately 10 h after discharge 
complaining of severe pain and swelling in the operative leg, 
chest pain, and shortness of breath. He was diagnosed with a 
deep vein thrombosis in the operative leg and a pulmonary 
embolus. With appropriate anticoagulation therapy, his 
symptoms resolved over the following 12 h and he was dis-
charged the following day. No falls, catheter-related infec-
tions, or nerve injuries were observed in either group.
discussion
Described in 1946, the first continuous peripheral nerve 
block comprised a needle fixed adjacent to the brachial 
plexus using a cork secured with tape, permitting local 
anesthetic readministration throughout the surgical proce-
dure lasting multiple hours.12 However, to administer local 
anesthetic for multiple days, a catheter is required and was 
first described in 1951 to treat intractable hiccups.2 In this 
report, a straight, hollow-bore needle was percutaneously 
inserted to lie adjacent to the phrenic nerve, after which a 
polyethylene catheter was placed through the needle, the 
needle was removed over the catheter, and the catheter was 
then secured in place using cutaneous collodion. Although 
various design revisions such as the stimulating catheter 
were developed,13 the basic technique of inserting a cath-
eter either through or over a straight, hollow-bore needle 
has remained unchanged since the first report. However, 
in 2015, a suture-shaped needle and trailing catheter were 
Fig. 5. Effects of the suture versus through-the-needle catheter 
on postoperative pain score over time. Data are expressed as 
mean (diamond) and median (horizontal bar) with 25th through 
75th (box); whiskers extend to the most extreme observations 
within 1.5 times the interquartile range of the first and third quar-
tiles, respectively; circles represent outliers. At the 0.025 signifi-
cance level, using a noninferiority delta of 1.25 points, the suture 
method was found noninferior to the through-the-needle method 
for average pain score, least pain, and current pain on the first 
two postoperative days, but not on worst pain.
Fig. 6. Effects of the suture versus through-the-needle cath-
eter on postoperative opioid consumption over time. Data are 
expressed as mean (diamond) and median (horizontal bar) with 
25th through 75th (box); whiskers extend to the most extreme 
observations within 1.5 times the interquartile range of the first 
and third quartiles, respectively; circles represent outliers.
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introduced by Rothe et al.,4,5 offering an alternative peri-
neural catheter introduction method for the first time in 
more than six decades.1
Multiple potential benefits were proposed by the original 
investigators. Because the catheter remains within a two-di-
mensional plane, the initial placement of the local anesthet-
ic-distributing orifice may be clearly viewed by ultrasound 
and therefore located precisely adjacent to the target nerve, 
unlike through-the-needle catheters that rarely remain in 
plane. Subsequent orifice readjustment is also possible using 
ultrasound visualization.6,7 Another theoretical benefit of the 
suture-catheter design is that there is less likelihood of cath-
eter dislodgement because it is secured at two sites (entry 
and exit).14 However, the risk of internal dislocation might 
actually be increased because there is no slack between the 
orifice and anchoring locations therefore, the orifice might 
be pulled away from the nerve, possibly decreasing accurate 
local anesthetic deposition and thus compromising analge-
sia. In contrast, through-the-needle catheters usually have 
a variable amount of slack inserted between the catheter 
tip/orifice(s) and the skin anchor, allowing for a good deal 
of catheter retraction/withdrawal before the catheter tip 
location is altered relative to the nerve.15 In fact, a recent 
case series involving suture-type adductor canal catheters in 
volunteers reported a 100% success rate for initial in-plane, 
short-axis insertions, whereas 20% (3 of 15) were found to 
be displaced internally when rechecked the following day.7
Therefore, the findings of the current randomized, sub-
ject-masked, parallel-arm clinical trial are reassuring in that 
the new suture-type perineural catheters provided non-
inferior analgesia compared with traditional catheters for 
continuous popliteal-sciatic blocks after painful foot and 
ankle surgery. In these ambulatory subjects, the degree to 
which each type of catheter dislodged internally remains 
unknown. However, considering that the primary goal 
of clinicians (and patients) is achieving adequate analge-
sia—whereas the degree of any internal dislodgement is a 
surrogate endpoint—we believe that our findings remain 
highly relevant. The greater incidence of leakage in the tra-
ditional group may be an indication of a higher degree of 
internal orifice dislodgement compared with the suture-
type catheters. Alternatively, the decreased leakage may be 
attributable to the fact that the needle and catheter diam-
eters are equivalent, unlike through-the-needle techniques 
in which the needle must be larger than the catheter passing 
internally, leaving a larger hole in the skin relative to the 
remaining catheter after needle withdrawal.16
Relatedly, it is notable that three (9%) through-the-needle 
catheters were completely dislodged versus none in the suture 
group, although this difference did not reach statistical signif-
icance (P = 0.239), and the study was not powered to detect 
a difference in dislodgement rate. Popliteal-sciatic catheters, 
located behind a highly mobile joint in a location with sig-
nificant perspiration, are theoretically prone to dislodgement, 
with traditional catheters secured solely at the insertion site 
having dislodgement rates reportedly as high as 40%.17 Many 
methods of securing catheters to decrease dislodgement have 
been proposed, including the use of pig-tail shaped cathe-
ters, adhesives such as 2-octyl cyanoacrylate glue or other 
liquid adhesives at the insertion site,18,19 tunneling,20 inserting 
the catheter past the needle tip,15 securing the catheter to 
the skin with suture,21 and various taping/dressing strategies. 
However, all of these methods have in common the potential 
disadvantage that they secure a catheter at the level of the 
skin solely at the entry point, whereas the tip of the (usually 
flexible) catheter remains unanchored.17
Hypothetical increased risks of the new suture-type cath-
eter design must be considered in addition to the theoret-
ical benefits. One possible risk is an increased incidence of 
infection with two skin penetration sites rather than the sin-
gle site associated with traditional perineural catheters (no 
infections occurred in either treatment group of our study).22 
Previous reports of suture-type catheter placement have left 
a longer tail at the exit site, possibly to increase the ease of 
subsequently repositioning a displaced catheter.6,7 However, 
in ambulatory patients such as those of the current investiga-
tion, leaving a long tail at the catheter exit site and asking the 
patients to sterilize and trim this tail before catheter removal 
was deemed to be too difficult and unacceptably increase the 
infection risk for patients or their caregivers to accomplish at 
home without direct medical supervision. Therefore, a tail of 
only approximately 1 cm was left at the catheter exit site. To 
table 3. Comparisons of the Suture Method versus Through-
the-needle on Tertiary Outcomes
tertiary outcomes
Suture-catheter 
(n = 35)
through-the- 
needle (n = 35) P value*
Catheter dislodgement 0 (0) 3 (9) 0.239
 POD 1 0 1  
 POD 2 0 1  
 POD 3 0 1  
Sleep disturbances 20 (57) 26 (74) 0.131
 POD 1 13 18  
 POD 2 8 21  
 POD3 6 5  
 POD4 4 9  
Opioid side effects 13 (37) 14 (40) 0.806
 POD 1 5 7  
 POD 2 7 6  
 POD 3 5 7  
 POD 4 3 3  
Local anesthetic side effects 0 (0) 0 (0) NA
 POD 1 0 0  
 POD 2 0 0  
 POD 3 0 0  
Leakage at site 2 (6) 11 (31) 0.006
 POD 1 0 7  
 POD 2 0 7  
 POD 3 2 4  
Values are reported as number of events (%). NA, not available; POD, postop-
erative day.
*From chi-square or Fisher exact test, as appropriate.
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prevent contamination of this tail during catheter extraction, 
the patients were specifically instructed to remove the dress-
ing over the entry (proximal) site, withdraw the catheter 
with gentle traction, and only then remove the exit (distal) 
site dressing, thus ensuring a contaminated distal catheter 
end was not withdrawn through the entire catheter track 
during removal. Risk to the provider should also be consid-
ered, and anesthesiologists who choose to use suture-type 
perineural catheters should be mindful of the risk of needle 
stick when advancing the needle through the exit site.
Additionally, the curvature of the suture-type needle both 
limits the possible target nerve depth and adds a level of com-
plexity that requires experience to overcome.23 The radius 
of the needle—of which there are currently three available 
(50, 75, and 120 mm)—combined with the needle length 
(100 vs. 160 mm available) and depth of the target nerve 
all determine the optimal entry (and exit) points. Perhaps 
helping to balance this increase in technical challenge, our 
subjective experience suggests that the curved needle is eas-
ier to visualize using ultrasound than linear counterparts.24 
Importantly, at the current time within the United States, 
there is only one brand of suture-type catheter available and 
it is cleared for use solely in the lower extremity.
It should be noted that the saphenous nerve block with 
20 ml 0.5% ropivacaine with 5 to 10 µg/ml epinephrine 
was of intermediate duration and likely resolved before the 
first follow-up telephone call in most or all cases. For this 
reason, pain scores at all follow-up points were not zero in 
most subjects and there was likely variability in the contri-
bution of saphenous distribution pain among subjects.
Study Limitations
Although the subjects of this investigation were masked to 
treatment group assignment, investigators were aware of the 
randomization results. In addition, the results apply only to 
the specific local anesthetic type, concentration, volume, and 
rate of the current study. Similarly, different anatomic loca-
tions,6,7 linear needle catheter brands and designs,16 suture-
type catheter orifice design (a multi-orifice catheter is 
available), ultrasound approaches (e.g., out-of-plane or long-
axis visualization),6,7,23 and catheter securement techniques 
(e.g., surgical glue, additional adhesive, tunneling, alterna-
tive taping strategies)18–20 would probably alter the results. 
The location for the catheter orifice—5 cm proximal to the 
bifurcation of the sciatic nerve and outside the paraneural 
sheath—was chosen based on a recent study demonstrat-
ing similar analgesic efficacy between this location and a 
distal, subparaneural placement for popliteal sciatic peri-
neural catheters.25 However, other recent studies involving 
single-injection blocks have found evidence for the use of 
the distal, subparaneural location as the optimal target of 
popliteal sciatic nerve blocks.26–28 The results of the present 
study, therefore, may be more relevant to anesthesiologists 
who choose a proximal, supraparaneural location for their 
catheter orifice when performing a popliteal sciatic nerve 
block. An additional limitation is the imbalance observed for 
age (absolute standard difference = 1.01), which occurred 
as a result of chance. To correct for this imbalance, age was 
adjusted for in all analyses. Finally, although the cathe-
ter insertion was considered successful with a decrease in 
temperature discrimination in the tibial nerve distribution, 
complete surgical-block success was not assessed.29
In conclusion, suture-type perineural catheters provided 
noninferior analgesia compared with traditional catheters 
for continuous popliteal-sciatic blocks after painful foot and 
ankle surgery. Therefore, the new catheter design appears 
to be a viable alternative to the traditional designs used 
for nearly 70 yr. However, further study is needed to thor-
oughly evaluate the risks and benefits of suture-type rel-
ative to traditional through- or over-the-needle catheters. 
Considering the potential benefits of decreased dislodge-
ment and leakage, improved ability to precisely control the 
placement of the catheter orifice, and the option of adjust-
ing a previously placed catheter under ultrasound visual-
ization, this new catheter design may have the potential to 
revolutionize perineural catheter placement.
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